Accessibility Menu
USANA Health Sciences logo

USANA Health Sciences(NYSE) USNA

Market Cap$276.41MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+2,355%
5 Year-85%
1 Year-53%
1 Month-0%
Premium Feature
Moneyball Superscore
43/100
$14.96
+3.67%
+0.53Today
USANA Health Sciences last closing stock price
MetricPriceDate
Last closeUSD 14.962026-09-04
USANA Health Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.55%USD 14.042026-08-28
1 month-0.2%USD 14.992026-08-05
3 month-17.03%USD 18.032026-06-05
Year to date-23.79%USD 19.632025-12-31
1 year-52.91%USD 31.772025-09-04
3 year-75.96%USD 62.222023-09-05
5 year-84.86%USD 98.842021-09-03
Since inception+2,354.97%USD 0.611995-07-24

USANA Health Sciences Financials at a Glance

Market Cap

$276.41MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$913.36M

Net Income (TTM)

-$22.16M

EPS (TTM)

-$1.20

P/E Ratio

-12.44

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$14.96

Volume

224,852.782

Open

$14.39

Previous Close

$14.96

Daily Range

$14.30 - $14.97

52-Week Range

$12.57 - $31.79

Estimated Earnings Date

Oct 28, 2026

USNA: Motley Fool Moneyball Superscore

43

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About USANA Health Sciences

USANA Health Sciences, Inc. makes vitamins and healthy snacks for families. It helps people improve their health with nutritional products. The company sells items through independent partners and online.

What USANA Puts in the Bottle

  • Core Nutritional Segment: Supplement and vitamin business using direct selling; represented 84% of net sales during the six months ended July 4, 2026.
  • Hiya Segment: Children's health products sold via a monthly subscription; accounted for 12.8% of net sales in the first six months of 2026.
  • Rise Segment: Simple-ingredient protein bars and drinks sold to national retailers; contributed 3.6% of net sales in the first six months of 2026.

Strategic Moves and New Markets

  • Acquired a 78.85% controlling interest in Hiya on Dec. 2, 2024.
  • Expanded the Rise product offering and distribution channels over the last three years.
  • Launched an Affiliate program in 2023 for the United States, Canada, and Mexico.
  • Introduced the Protein Pop product line in the third quarter of 2025.

Selling Beyond the Direct Model

The business uses an omni-channel platform including direct selling, subscriptions, and retail stores. It generates 91.1% of its Core Nutritional sales from markets outside the United States.

A Look at the Recent Numbers

  • Net sales fell to $223.3 million in the second quarter of 2026, down 5.3% year over year.
  • The company reported a net loss of $21.4 million for the second quarter of 2026.
  • A non-cash goodwill impairment charge reached $29.1 million during the second quarter of 2026.
  • Cash and cash equivalents grew to $168.6 million as of July 4, 2026.
  • Active customers in the Core Nutritional segment totaled 384,000 as of July 4, 2026.

The Big Picture

USANA has transitioned from a pure direct-selling model to a multi-channel health company. Strategic acquisitions like Hiya and Rise have diversified its customer base and distribution methods.

AI Generated • Aug 14, 2026

Industry

Personal Products

Employees

1,570

CEO

Kevin G. Guest

Headquarters

Salt Lake City, UT 84120, US

USNA Financials

Key Financial Metrics (TTM)

Gross Margin

77.45%

Operating Margin

1.35%

Net Income Margin

-2.43%

Return on Equity

-4.16%

Return on Capital

9.30%

Return on Assets

-3.15%

Earnings Yield

-8.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$276.41MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.48M

Volume

224.85K

Avg. Volume

162.96K

Financials (TTM)

Gross Profit

$707.36M

Operating Income

$12.35M

EBITDA

$32.59M

Operating Cash Flow

$27.73M

Capital Expenditure

-$11.79M

Free Cash Flow

$15.93M

Cash & ST Invst.

$168.56M

Total Debt

$0.00

USANA Health Sciences Performance Analysis

USANA Health Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 998,601,000-15.8%
20232023-12-31USD 921,010,000-7.8%
20242024-12-31USD 854,503,000-7.2%
20252025-12-31USD 925,257,0008.3%
USANA Health Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-27-9.4%
Q42026-01-035.9%
Q12026-04-0410.6%
Q22026-07-04-10.8%
USANA Health Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.59-37.3%
20232023-12-31USD 3.30-8.2%
20242024-12-31USD 2.19-33.5%
20252025-12-31USD 0.58-73.6%
USANA Health Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-27-169.2%
Q42026-01-0373.1%
Q12026-04-04522.7%
Q22026-07-04-382.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$223.27M

-5.3%

Gross Profit

$174.93M

-1.7%

Gross Margin

78.35%

N/A

Market Cap

$276.41MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$176.06K

N/A

Employees

1,570

N/A

Net Income

-$21.38M

-321.5%

EBITDA

-$18.90M

-165.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$168.56M

+11.4%

Total Debt

$0.00

N/A

Accounts Receivable

$3.34M

N/A

Inventory

$86.34M

+3.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-3.15%

N/A

Return on Invested Capital

2.07%

N/A

Free Cash Flow

$20.16M

+180.4%

Operating Cash Flow

$23.32M

+90.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BRCCBRC Inc.
$8.75+1.86%
BGSB&G Foods, Inc.
$3.29-2.08%
LNDBrasilAgro - Companhia Brasileira de Propriedades Agrícolas
$3.79-2.07%
LWAYLifeway Foods, Inc.
$25.01-2.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About USNA

What is the current price of USANA Health Sciences?

USANA Health Sciences is trading at $14.96 per share.

What is the 52-week range for USANA Health Sciences?

Over the past 52 weeks, USANA Health Sciences has traded between $12.57 and $31.79.

How much debt does USANA Health Sciences have?

As of the most recent reporting period, USANA Health Sciences reported total debt of $0.00.

How much cash does USANA Health Sciences have on hand?

USANA Health Sciences reported $168.56M in cash and cash equivalents in its most recent financial results.

What is USANA Health Sciences’s dividend yield?

USANA Health Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.